'A multicenter double-blind, placebo-controlled randomized pilot study evaluating efficacy and safety of ETN in patients with moderate to severe plaque psoriasis after cessation of ciclosporin therapy'
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2012
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms SCORE
- Sponsors Pfizer
- 24 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2006-004454-25).
- 20 Apr 2012 Company added as trial sponsor as reported by ClinicalTrials.gov.
- 20 Apr 2012 Actual patient number changed from 154 to 120 as reported by ClinicalTrials.gov.